Global Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
In the last several years, global market of Pneumococcal Vaccine developed rapidly generally, while global production growth rate of Pneumococcal Vaccine experienced slight fluctuations due to patent validity. In 2016, global production of Pneumococcal Vaccine is nearly 126 million doses. The Revenue of Pneumococcal Vaccine is around 6768 M USD in 2016.
Scope of the Report:
This report focuses on the Pneumococcal Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Pneumococcal Vaccine market.
Chapter 1, to describe Pneumococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pneumococcal Vaccine, with sales, revenue, and price of Pneumococcal Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Vaccine, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook